In this study, the measurement of the plasma capacity to inhibit exogenous plasma kallikrein showed a better capacity to distinguish between controls and HAE-C1-INH patient’s samples during remission and attacks (63). The gene discussed is KLK4; the disease is hereditary angioedema.